{"id":"W2910240398","doi":"10.1182/blood-2018-99-117251","title":"Prolonged Overall Survival (OS) in a Subset of Responders to the Combination of Brentuximab Vedotin (Bv) and Bendamustine (B) in Heavily Treated Patients with Relapsed or Refractory Hodgkin Lymphoma (HL): Results of an International Multi- Center Phase I/II Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Bendamustine; Refractory (planetary science); Population; Gastroenterology; Chemotherapy; Oncology; Lymphoma; Surgery; Hodgkin lymphoma; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006885306,0.0002060324,0.0003332784,0.0001919745,0.0002134491,0.0003745172,0.0001878094,0.0002216107,0.0006002594],"category_scores_gemma":[0.0005052632,0.00009246371,0.0002419104,0.0001808414,0.00021412,0.0002194879,0.0001976456,0.000370935,0.0001316035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000207459,"about_ca_system_score_gemma":0.0001859523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000379992,"about_ca_topic_score_gemma":0.0006540876,"domain_scores_codex":[0.9997879,0.00009427277,0.0000215685,0.00003820811,0.00002376834,0.00003441533],"domain_scores_gemma":[0.9996965,0.00008675428,0.00006781335,0.00001758833,0.00001964022,0.0001117183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03445534,0.003263305,0.809842,0.0001706297,0.0004149254,0.001314657,0.0007380866,0.001203266,0.03307172,0.0000807465,0.001243549,0.1142018],"study_design_scores_gemma":[0.003420512,0.06125648,0.920623,0.00005070986,0.0005425889,0.003324378,0.0004266415,0.002583528,0.004486111,0.0001205917,0.003138993,0.00002646917],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992404,0.0003922268,0.00007328034,0.00003029336,0.000002804312,0.00001627976,0.00005852668,0.000002823866,0.000183274],"genre_scores_gemma":[0.9994517,0.0001686956,0.0000917122,0.000050379,0.00001385257,0.00001172611,0.0001421702,9.801641e-7,0.00006881988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006885306,"threshold_uncertainty_score":0.003641367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02156620359422697,"score_gpt":0.2996807255284848,"score_spread":0.2781145219342578,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}